XML 18 R2.htm IDEA: XBRL DOCUMENT v3.20.4
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2020
Dec. 31, 2019
Assets    
Fixed maturity investments trading, at fair value - amortized cost $13,155,035 at December 31, 2020 (2019 - $11,067,414) (Notes 5 and 6) $ 13,506,503 $ 11,171,655
Short term investments, at fair value (Notes 5 and 6) 4,993,735 4,566,277
Equity investments trading, at fair value (Notes 5 and 6) 702,617 436,931
Other investments, at fair value (Notes 5 and 6) 1,256,948 1,087,377
Investments in other ventures, under equity method (Note 5) 98,373 106,549
Total investments 20,558,176 17,368,789
Cash and cash equivalents 1,736,813 1,379,068
Premiums receivable (Note 7) 2,894,631 2,599,896
Prepaid reinsurance premiums (Note 7) 823,582 767,781
Reinsurance recoverable (Notes 7 and 8) 2,926,010 2,791,297
Accrued investment income 66,743 72,461
Deferred acquisition costs and value of business acquired 633,521 663,991
Receivable for investments sold 568,293 78,369
Other assets 363,170 346,216
Goodwill and other intangible assets (Note 4) 249,641 262,226
Total assets 30,820,580 26,330,094
Liabilities    
Reserve for claims and claim expenses (Note 8) 10,381,138 9,384,349
Unearned premiums 2,763,599 2,530,975
Debt (Note 9) 1,136,265 1,384,105
Reinsurance balances payable 3,488,352 2,830,691
Payable for investments purchased 1,132,538 225,275
Other liabilities 970,121 932,024
Total liabilities 19,872,013 17,287,419
Commitments and Contingencies (Note 20)
Redeemable noncontrolling interests (Note 10) 3,388,319 3,071,308
Shareholders’ Equity (Note 12)    
Preference shares: $1.00 par value – 11,010,000 shares issued and outstanding at December 31, 2020 (2019 – 16,010,000) 525,000 650,000
Common shares: $1.00 par value – 50,810,618 shares issued and outstanding at December 31, 2020 (2019 – 44,148,116) 50,811 44,148
Additional paid-in capital 1,623,206 568,277
Accumulated other comprehensive loss (12,642) (1,939)
Retained earnings 5,373,873 4,710,881
Total shareholders’ equity attributable to RenaissanceRe 7,560,248 5,971,367
Total liabilities, noncontrolling interests and shareholders’ equity $ 30,820,580 $ 26,330,094